Browsing by Author "Yazilitas, Dogan"
Now showing items 1-4 of 4
-
Multicenter experience of adult medulloblastoma: A study of Anatolian Society of Medical Oncology (ASMO)
Esbah, Onur; Demirci, Umut; Dane, Faysal; Gunaydsin, Yusuf; Ozdemir, Nuriye; Ekinci, Ahmet Siyar; Kodaz, Hilmi; Yazilitas, Dogan; Rzayev, Rashad; Guney, Yildiz; Seker, Metin; Uysal, Mukremin; Inal, Ali; Bilici, Ahmet; Benekli, Mustafa; Oksuzoglu, Berna; Buyukberber, Suleyman (ZERBINIS MEDICAL PUBL, 2016)Purpose: Medulloblastoma (MB) is rarely seen in adults. For adjuvant therapy in adults the same therapy protocols used in pediatric cases are used. The present study retrospectively evaluated the data of MB patients who ... -
Recurrence Risk and Prognostic Parameters in Stage I Rectal Cancers
Cihan, Sener; Kucukoner, Mehmet; Ozdemir, Nuriye; Dane, Faysal; Sendur, Mehmet Ali Nahit; Yazilitas, Dogan; Urakci, Zuhat; Durnali, Ayse; Yuksel, Sinemis; Aksoy, Sercan; Colak, Dilsen; Seker, Mehmet Metin; Taskoylu, Burcu Yapar; Oguz, Arzu; Isikdogan, Abdurrahman; Zengin, Nurullah (ASIAN PACIFIC ORGANIZATION CANCER PREVENTION, 2014)Background: The standard therapy for stage I rectum cancer is surgical resection. Currently, there is no strong evidence to suggest that any type of adjuvant therapy is beneficial. The risks of local relapse and distant ... -
Retrospective analysis of 178 patients with stage I rectum cancer.
Cihan, Sener; Ozdemir, Nuriye; Urakci, Zuhat; Kucukoner, Mehmet; Dane, Faysal; Yazilitas, Dogan; Durnali, Ayse; Yuksel, Sinemis; Colak, Dilsen; Seker, Metin; Taskoylu, Burcu; Aksahin, Arzu; Ozturk, Banu; Demirci, Umut; Turan, Nedim; Aksoy, Sercan; Atasoy, Ajlan (AMER SOC CLINICAL ONCOLOGY, 2013)… -
XELOX Plus Bevacizumab vs. FOLFIRI Plus Bevacizumab Treatment for First-line Chemotherapy in Metastatic Colon Cancer: a Retrospective Study of the Anatolian Society of Medical Oncology
Duran, Ayse Ocak; Karaca, Halit; Besiroglu, Mehmet; Bayoglu, Ibrahim Vedat; Menekse, Serkan; Yapici, Heves Surmeli; Yazilitas, Dogan; Bahceci, Aykut; Uysal, Mukremin; Sevinc, Alper; Hacibekiroglu, Ilhan; Aksoy, Asude; Tanriverdi, Ozgur; Arpaci, Erkan; Inanc, Mevlude; Dane, Faysal; Ozkan, Metin (ASIAN PACIFIC ORGANIZATION CANCER PREVENTION, 2014)Background: XELOX plus bevacizumab (XELOX-Bev) and FOLFIRI plus Bevacizumab (FOLFIRI - Bev) treatments are an effective strategies patients with metastatic colorectal cancer (mCRC). The aim of this study was to compare ...